The predictive value of C-reactive protein (CRP) and procalcitonin chemical biomarkers in the premature diagnosis of infection in  brain ischemic stroke by Najafi, Narges et al.
  
 
http://cdjournal.muk.ac.ir,    06 July  
    Chron Dis J, Vol. 7, No. 3, Summer 2019   175 
DOI: 10.22122/cdj.v7i3.464 Published by Vesnu Publications 
The predictive value of C-reactive protein (CRP) and procalcitonin 
chemical biomarkers in the premature diagnosis of infection in  
brain ischemic stroke 
 
Narges Najafi
1,2
, Alireza Davoudi
1,2
, Shahriar Alian
1,2
, Fatemeh Ahangarkani
3,4
,  
Mahmoud Abedini
5
, Roshina Hassantabar
1,2
, Reza Maleki-Gorji1,2, Salar Behzadnia1 
 
1 Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, Iran 
2 Department of Infectious Diseases, Mazandaran University of Medical Sciences, Sari, Iran 
3 Student Research Committee, Antimicrobial Resistance Research Center, Mazandaran University of Medical 
Sciences, Sari, Iran 
4 Universal Scientific Education and Research Network, Tehran, Iran 
5 Department of Neurology, Mazandaran University of Medical Sciences, Sari, Iran 
 
Abstract 
BACKGROUND: The infections are common complications after the ischemic stroke. The aim of this study was to 
evaluate the anticipatory value of C-reactive protein (CRP) and procalcitonin (PCT) biomarkers in diagnosis of 
stroke-induced infection. 
METHODS: In the current prospective study, 184 patients with cerebral ischemia were enrolled. Serum samples were 
obtained from patients. The CRP and PCT, white blood cells (WBCs) and monocytes, and final infections were evaluated. 
RESULTS: In the first 72 hours, the analysis for CRP revealed that the sensitivity was 41.60%, the specificity was 
100%, positive predictive value (PPV) was 100%, and negative predictive value (NPV) was 82.90%. PCT showed 
that the sensitivity was 85.41%, the specificity was 98.54%, PPV was 95.34%, and NPV was 95%. 
CONCLUSION: According to our findings, the evaluation of CRP and PCT with simultaneous clinical observation 
could be considered as a good step in start of antibiotic therapy. 
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Introduction1 
In 25-65 percent of the patients, the infection 
occurs in the first few days after ischemic 
stroke.1,2 Pneumonia (the infection of 
pulmonary parenchyma) and the urinary tract 
infection (UTI) are the most common infectious 
complications after the ischemic stroke.3 It has 
been stated that increasing the probability of 
infection during the acute phase of stroke is 
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due to immune suppression.4 The central 
nervous system (CNS) adjusts the function of 
immune system through a complicated path 
including hypothalamus-pituitary-adrenal axis 
(HPA axis) and the vague nerve as well as 
sympathetic nervous system (SNS).5,6 The 
results of many studies reveal that there is an 
independent association between the infection 
caused by stroke and the poor functional 
outcome after that.7-9 Therefore, in case the 
infection emerges in the incipient stage of the 
illness, antibiotic treatment is recommended.10 
However, the clinical gold standard method is 
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time-consuming for diagnosis and delays the 
antibiotic treatment. Thus, the simple precise 
diagnostic markers are required to determine 
the amount of risk. In the other studies, the  
C-reactive protein (CRP), white globules, and 
monocytes were examined as the accepted 
inflammatory markers regarding their easy 
and common measurement. Procalcitonin (PCT) 
is selected to differentiate infection from general 
inflammation.11-17 All of these biomarkers are 
available due to easy and quick interpretation.  
The values of blood markers such as white 
blood cell (WBC), CRP, and monocyte as a 
predictor of infection resulting from the stroke 
have not adequately been explored; however, 
they are assessed routinely after the admission 
of patients. In a study, the biomarkers like 
CRP, WBC, monocyte, and PCT were sensitive 
enough to diagnose the infection caused by 
stroke, but in another one, they did not have 
enough sensitivity. Thus, due to lack of 
evidence we cannot be certain about their role 
in predicting the infection caused by stroke.13,14 
Approximately, one-third of deaths and 
serious complications are caused by the 
subsequent complications especially infection.  
The changes of the immune markers and 
stress, the reduction of human leukocyte 
antigen–DR isotype (HLA-DR) for instance, or 
increasing the serum level of catecholamine 
occur during the incipient stage of stroke and 
justify the high inclination of these patients to 
bacterial infection after stroke. It is imagined 
that these blood markers can predict the 
occurrence of post-stroke infection to a high 
extent. Thus, considering the importance of 
early treatment in patients with stroke, its high 
incidence, the dramatic infection resulting 
from that, and taking this point into account 
that early treatment of these patients has a 
great influence on their life style and function, 
in this study we attempt to investigate the 
predictive value of CRP and PCT chemical 
biomarkers in the premature diagnosis of the 
ischemic stroke. First, we are to evaluate the 
diagnostic value of each biomarker in 
predicting the incipient phase of infection and 
then proceed with specifying that which one 
has a better diagnostic value. 
Materials and Methods 
This prospective longitudinal study was 
conducted on the patients explored in the course 
of January, 2014 to March, 2015. It was approved 
by the Ethics Committee of Mazandaran 
University of Medical Sciences, Sari, Iran (code 
number: 458, date: December 24, 2013). 
First, the experimental studies were carried 
out; then the patients were followed-up 
clinically before manifestation of infection and 
the relationship between this occurrence and 
the experimental level of each parameter was 
measured. The sampling method was non-
probable and purposeful. The study was carried 
out in Razi Hospital in Qaemshahr, Iran, and 
Bou Ali Sina Hospital in Sari. The inclusion 
criterion was that all the patients should be 
afflicted by the acute ischemic stroke (AIS) in 
the first 72 hours before admission. All of the 
patients signed a consent form for entrance and 
10 cc blood was taken from the patients 
voluntarily, considering the ethics. Stroke was 
verified by computed tomography (CT) scan or 
magnetic resonance imaging (MRI). The 
neurologic disorder was scored using the rating 
system of the National Health Center for Stroke. 
The infection caused by stroke includes every 
infection in the first 5 days of hospitalization.13,14 
Infection is diagnosed by the standards of the 
center for disease control (CDC).15 With regard 
to the outbreak of the type of infection, they fall 
into three categories including pneumonia (the 
infection of pulmonary parenchyma), urinary 
tract infection (UTI), and other infections. The 
pneumonia is confirmed when there is at least 
one of the following criteria (the first or 
subsequent part): 1. examination of abnormal 
respiration or pulmonary infiltrates in the chest 
radiography [chest X-ray (CXR)], 2. productive 
cough along with purulent sputum, the positive 
microbial culture from the lower respiratory 
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tract secretions or the positive blood culture. 
The diagnosis of UTI is based on the two 
following cases: the fever ≥ 38 ºC, the positive 
nitrite in the urine sample, leukocyte > 40% in 
each microliter of urine, and bacteria > 104 in a 
type of pathogen microbe. Other infections are 
verified if the fever is above 38 ºC, WBC is 
above 11000 in each milliliter or CRP is ≥ 10 
m/l, and if the clinical manifestation of 
infection exists. Determining infection is based 
on the country's standard protocol. The time of 
diagnosis depends upon the beginning of 
clinical manifestations and symptoms that lead 
to the beginning of diagnostic measurements, as 
a result, the infection is diagnosed. In order to 
prevent the entrance of people who had 
infection before stroke, the patients with the 
fever of more than 38 degree before admission, 
those who had infection 3 days before stroke, 
and people who need mechanical intubation 
were not allowed in the study. The other 
excluding criteria included being 
immunosuppressive and being afflicted by 
human immunodeficiency virus (HIV) and the 
other immune system deficiencies. The blood 
samples were taken at the first 72 hours of 
hospitalization and after three days to examine 
WBC, monocyte (Sysmex KX-21N, Kobe, 
Japan), and the level of CRP and PCT. The 
amount of CRP was measured by immune 
turbid metric assay (Pars Azmoon Co., Tehran, 
Iran). The serum level of PCT was measured 
using enzyme-linked immunosorbent assay 
(ELISA) (Kryptor PCT®, BRAHMS, 
Hennigsdorf, Germany).16 The statistical 
analysis was carried out using SPSS software 
(version 18, SPSS Inc., Chicago, IL, USA). The 
descriptive statistical indexes such as mean, 
standard deviation (SD), median, and absolute 
and relative frequencies depending on 
distribution were calculated. The difference 
between the groups was evaluated by Kruskal-
Wallis or chi-square tests. In addition, the 
simple logistic regression test, the measured 
biomarkers, and the existence of infection were 
investigated and P-value ≤ 0.0500 was 
considered as the significant level. 
Results 
The study consisted of 184 members, among 
which 108 people (58.7%) were men and  
76 people (41.3%) were women. The mean of 
the age of study members was 68.52 ± 9.48 
years. The lowest age was 48 years and the 
highest was 91 years. All of the patients were 
examined in terms of being afflicted by 
infection in the hospitalization process. To sum 
up, 48 patients (26.1%) afflicted by a kind of 
infection were specified. 10 patients (4.5%) 
were afflicted by urine infection among which 
7 were women and 3 were men. In 
investigating the infection of respiratory 
system, it was revealed that 33 patients were 
afflicted by the infection. Totally, 5 male 
patients were afflicted by the other infections. 
All of the patients were investigated in terms 
of the number of white globules, monocytes, 
CRP, and PCT, and after three days the 
experimental markers were evaluated. 
Comparing the two durations of the 
experiment revealed that all of the 
experimental characteristics had significant 
statistical distinction (P = 0.0001) (Tables 1-3). 
 
Table 1. Result of laboratory tests in the first 72 hours 
Laboratory test First 72 hours 
Men 
Mean ± SD 
Women 
Mean ± SD 
Total 
Mean ± SD 
WBC (/µl) 7776.36 ± 1723.33 7143.77 ± 1440.21 7515.07 ± 1638.33 
Monocyte 2.45 ± 0.98 2.23 ± 0.88 2.36 ± 0.88 
CRP 7.40 ± 4.25 6.32 ± 2.16 6.95 ± 3.58 
PCT 465.81 ± 259.12 347.46 ± 176.06 416.93 ± 235.32 
WBC: White blood cell; CRP: C-reactive protein; PCT: Procalcitonin; SD: Standard deviation 
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Table 2. Result of laboratory tests in the second 72 hours 
Laboratory test Next 72 hours 
Men 
Mean ± SD 
Women 
Mean ± SD 
Total 
Mean ± SD 
WBC 13116.42 ± 6060.83 11577.35 ± 10874.29 12480.72 ± 8397.54 
Monocyte 3.25 ± 1.86 2.69 ± 1.29 3.02 ± 1.67 
CRP 13.51 ± 10.27 10.71 ± 7.32 12.35 ± 9.25 
PCT 1205.74 ± 1202.84 713.77 ± 615.24 1002.53 ± 1000.00 
WBC: White blood cell; CRP: C-reactive protein; PCT: Procalcitonin; SD: Standard deviation 
 
Table 3. Results of biomarkers in these cases 
Biomarkers  First 72 hours Next 72 hours 
 Infection Infection 
 Yes No Yes No 
CRP Positive 20 0 44 126 
Negative 28 136 4 10 
PCT Positive 41 2 47 29 
Negative 7 134 1 107 
CRP: C-reactive protein; PCT: Procalcitonin 
 
This study was an attempt to evaluate the 
predictive value of CRP and PCT. In exploring 
the patients' CRP in the first 72 hours of 
admission of irritation, ability of the screening 
test in the diagnosis of patients was 41.60%, the 
sensitivity showing the ability of screening in 
diagnosis of the elderly was 100%, the positive 
predictive value (PPV) of patients was 100% in 
the first 72 hours with regard to CRP which 
represents that all of the infected patients had 
high CRP and the negative predictive value 
(NPV), which is the probability of not being 
infected, was 82.90%. Having been investigated, 
CRP was 91.60% after three days of admission, 
sensitivity was 93.15%, the PPV was 81.48%, and 
the NPV was 96.92%. The investigation of PCT in 
the first 72 hours of hospitalization revealed that 
irritation was 85.41%, sensitivity was 98.54%, the 
PPV was 95.34%, and the NPV was 95.02%. In 
addition, according to the experiment three days 
after, the PCT of irritation was 97.91%, 
sensitivity was 78.67%, the PPV was 61.84%, and 
the NPV was 99.07%. 
Discussion 
The results of this study revealed that totally 
48 patients (26.1%) were afflicted by one of the 
infections. It was specified that 10 patients 
(4.5%) were afflicted by the urine infection and 
in exploring the respiratory system, it was 
represented that 33 patients were infected. 
Totally, 5 male patients were afflicted by the 
other infections. In this study, it was attempted 
to evaluate the predictive value of CRP and 
PCT. Investigating the CRP of the patients in 
the first 72 hours represented that the 
admission of irritation was 41.60%, sensitivity 
was 100%, the PPV was 100%, and the NPV 
was 82.90%. Investigating PCT in the first 72 
hours revealed that sensitivity was 85.41%, 
specificity was 98.54%, the PPV was 95.34%, 
and the NPV was 95.02%. In a study carried 
out by Tian et al. in china, the role of PCT in 
the cerebral ischemia was investigated. The 
results revealed that the amount of PCT was 
significantly higher in the patients with 
cerebral ischemia than in the control group.18 
As the results of the current study, in the study 
carried out by Fluri et al., the predictive role of 
CRP, PCT, and WBC in the creation of 
infection in stroke was investigated. They 
examined 383 patients with stroke, 66 of which 
were afflicted by the post-stroke infection. The 
results suggested that in the patients with high 
rate of such factors, the incidence of 
pneumonia and urine infection was higher in 
the first 5 days after admission.19 In the 
research conducted by Worthmann et al., the 
role of inflammatory factors in the cerebral 
ischemia infection was investigated. In their 
study, they measured the role of inflammatory 
factors in 56 patients. The results revealed that 
the incidence of infection after stroke was more 
in the patients with high inflammatory factors 
like CRP.20 The results of Welsh et al.’s study 
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represented that CRP had a high connection 
with the occurrence of the serious subsequent 
complications. They revealed that the CRP 
biomarker accompanied the complications of 
stroke independently.21 In another study 
carried out by Deng et al., the role of PCT was 
evaluated in the outcome of cerebral ischemia. 
In a prospective longitudinal study in which 
they examined 378 patients, they revealed that 
PCT in the cerebral ischemia was applicable as 
a predictive marker in the short-term 
complications of cerebral ischemia.22 The study 
of Wang et al. manifested that in the patients 
with weaker clinical results and higher 
mortality, the amount of PCT and the CRP 
biomarkers was significantly higher. In 
addition, comparing the PCT and the CRP 
markers in these patients represented that the 
amount of PCT in the time of admission had a 
significant relationship with the clinical results 
after the release of the patients; however, this 
finding was not verified in case of CRP.23 Our 
research also verified the above-mentioned 
results, but in our study, the results after 
releasing from hospital were not evaluated. To 
confirm the results of this study, in another 
study carried out by Xie et al., the role of PCT 
and the CRP biomarkers in the pneumonic 
survival after stroke was investigated. First, 
they examined 207 patients with cerebral 
ischemia, 91 cases of which were afflicted by 
pneumonia and 39 cases passed away.24 The 
irritation and feature of PCT in the diagnosis of 
pneumonia were 84.6% and 71.2%, respectively. 
In addition, the amount of PCT and the CRP 
biomarkers was higher in the infected group. 
They declared that measuring the inflammatory 
markers and PCT was useful in the prediction 
of the cerebral ischemia complications. 24 
Conclusion 
This study reveals that the inflammatory 
factors that appear with the positive or 
negative biomarkers in the experiments, have a 
determining role in the prognosis of patients 
afflicted by the cerebral ischemic stroke, and 
maybe in the future, with regard to this effect, 
we can help the patients recover through 
applying new therapeutic strategies. However, 
considering the convenience and the speed of 
the experiment, it can be used as a part of tools 
of checking sepsis. Measuring the level of CRP 
and PCT along with a proper clinical 
evaluation can be a guide for antibiotic 
treatment and can enhance the patients’ pre-
consciousness. In case of using this test, both 
the strengths and weaknesses of these 
biomarkers should be taken into account for 
making decision. Measuring the serum level of 
PCT with acceptable irritation and feature can 
help antibiotic treatment, but it cannot be used 
as the only diagnostic marker and replaced by 
the clinical judgment of the physician. The 
researchers of this study support the measuring 
value of the level of CRP and PCT as a part of 
investigating diagnosis; and to reach more 
certain results, they consider conducting more 
research in this area necessary. 
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